Anika Therapeutics Competitors and Similar CompaniesClear all
Anika Therapeutics's competitors and similar companies include Ajinomoto Bio-Pharma Services, Evofem Biosciences, Revance Therapeutics and Hallura.
 Anika Therapeutics Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. |  Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). |  Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products. |  Revance Therapeutics Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings. |  Hallura Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers. | |
Founding Date | Founding Date 1992 | Founding Date 1998 | Founding Date 2007 | Founding Date 2002 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Bedford, US HQ Padova, IT Padova, IT Franklin, US | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP | Locations San Diego, US HQ | Locations Nashville, US HQ Irvine, US Newark, US Pleasanton, US | Locations Yokne'am Illit, IL HQ |
Employees | Employees 15416% increase | Employees 68610% decrease | Employees 3030% increase | Employees 59712% increase | Employees 215% increase |
Valuation ($) | Valuation ($) 365 m | Valuation ($) N/A | Valuation ($) 1.2 m | Valuation ($) 615.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $112.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $20.2m (FY, 2025) | Revenue (est.) $234m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $49m (FY, 2025) | Cost of goods N/A | Cost of goods $4.6m (FY, 2025) | Cost of goods $74.4m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $63.8m (FY, 2025) | Gross profit N/A | Gross profit $15.6m (FY, 2025) | Gross profit $159.7m (FY, 2023) | Gross profit N/A |
Net income | Net income ($10.9m) (FY, 2025) | Net income N/A | Net income $391k (FY, 2025) | Net income ($324m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Ajinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View companyEvofem Biosciences
HQ
San Diego, US
Employees
30↑ 30% increase
Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.
View companyRevance Therapeutics
HQ
Nashville, US
Employees
597↑ 12% increase
Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.
View companyHallura
HQ
Yokne'am Illit, IL
Employees
21↑ 5% increase
Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers.
View company